Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted 24 June, 2010 and appeared in  ObesityType 2 DiabetesIssue 527

Test Your Knowledge #527: An African-American Man with Type 2 Diabetes and Obesity, Part Two of Three

Mr. Barton is a 64-year-old African-American referred by his primary care physician for evaluation of his Type 2 diabetes. His history with Type 2 diabetes includes:

Advertisement
  • Diagnosis 5 years ago, with an A1C of 6.7%
    • Initially able to control his diabetes with exercise and improvement to his diet
  • A1C of 7.8% 2 years following diagnosis
    • Started on glipizide ER, 5 mg daily
    • Glipizide ER increased 3 months later to 10 mg daily
  • A1C of 8.4% 2 years later (4 years following diagnosis) with weight gain of 15 pounds
    • Metformin added to glipizide ER regimen, started at 500 mg to minimize gastrointestinal (GI) effects
    • Metformin titrated up to 1000 mg twice daily

Mr. Barton has now been on the glipizide ER plus metformin regimen for 1 year. 

In addition to diabetes, he has a 20-year history of dyslipidemia and an 18-year history of hypertension.

Case Presentation:

Mr. Barton works as a high school physics teacher and is married with 2 grown children. His father had Type 2 diabetes and died of cardiovascular disease (CVD) at age 58; his mother is currently treated for hypertension but is otherwise healthy. When Mr. Barton was first diagnosed, he played golf regularly. He was forced to stop due to chronic back pain, and has not found another exercise activity he enjoys. 

He and his wife met with a dietitian once when he was first diagnosed, but he has not had any recent diabetes education. He states that his wife made some dietary changes at home after his diagnosis, but they still eat out for many meals and have slipped back into familiar eating patterns. 

Mr. Barton is concerned that he will need to start on insulin. Although he is not fearful of injections, he has read that insulin may lead to weight gain -- he does not want to gain more weight because he is afraid it may worsen his back pain and increase his CVD risk. 

Case Details
Physical exam / review of systems
Laboratory values

Overweight male in no acute distress

A1C 8.1%
Height 74 inches

Fasting glucose average: 155 mg/dL

Weight 268 lbs

Postprandial glucose not measured

Waist circumference 43 inches

LDL 75 mg/dL
BMI 34.3 kg/m2
HDL 40 mg/dL

Blood pressure 135/82 mmHg

Triglycerides 100 mg/dL

Background diabetic retinopathy

Creatinine 1.3 mg/dL

Remainder of physical exam normal

Estimated GFR 72 mL/min

Current medications

Urine microalbumin 10 µg/mg creatinine

Liver function tests within normal limits

Glipizide ER 10 mg daily
 

Metformin 1000 mg twice daily

Simvastatin 40 mg daily

Lisinopril 20 mg daily

Hydrochlorothiazide 25 mg daily

Aspirin 81 mg daily
Multivitamin daily
 

A GLP-1 receptor agonist was added to his treatment to help this patient meet his goal of improving glycemic control without causing weight gain.

Question 2 

Based on Mr. Barton's initial presentation and laboratory values, what treatment options would you recommend to treat his hyperglycemia and minimize weight gain? (Please select the most appropriate response.)

A.    Discontinue glipizide ER, continue metformin 1000 mg twice daily, and add basal insulin once daily. 

B.    Continue metformin 1000 mg twice daily, decrease glipizide ER to 5 mg daily and add exenatide 5 g twice daily. 

C.    Continue metformin 1000 mg twice daily and glipizide ER 10 mg daily and add sitagliptin 100 mg daily.

D.    Either answer "B" or "C" would be appropriate.

For the correct answer, please click here.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 24 June, 2010 and appeared in  ObesityType 2 DiabetesIssue 527

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control